Dianthus Therapeutics, Inc. /DE/ Quarterly Retained Earnings (Accumulated Deficit) in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Dianthus Therapeutics, Inc. /DE/ quarterly Retained Earnings (Accumulated Deficit) history and growth rate from Q4 2017 to Q3 2024.
  • Dianthus Therapeutics, Inc. /DE/ Retained Earnings (Accumulated Deficit) for the quarter ending September 30, 2024 was -$146M, a 85.1% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 -$146M -$67.1M -85.1% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$121M +$314M +72.2% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$103M +$328M +76.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$89.4M -$43.6M -95% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 -$78.9M +$40K +0.05% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$434M -$68.7M -18.8% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 -$431M -$82.7M -23.7% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$45.9M -$28.5M -164% Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$78.9M +$227M +74.2% Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$366M -$76.9M -26.6% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 -$349M -$76.6M -28.2% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$17.4M +$237M +93.2% Dec 31, 2021 8-K 2023-12-21
Q3 2021 -$306M -$70M -29.6% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 -$289M -$70.3M -32.1% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 -$272M -$72.4M -36.3% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 -$254M -$74.9M -41.7% Dec 31, 2020 10-K 2022-03-08
Q3 2020 -$236M -$80M -51.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 -$219M -$83.3M -61.6% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 -$200M -$81.9M -69.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 -$179M -$76.8M -74.7% Dec 31, 2019 10-K 2021-03-03
Q3 2019 -$156M -$70.2M -81.6% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 -$135M -$65.2M -93.2% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 -$118M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 -$103M -$57.5M -127% Dec 31, 2018 10-K 2020-03-03
Q3 2018 -$86M Sep 30, 2018 10-Q 2018-11-08
Q2 2018 -$70M Jun 30, 2018 10-Q 2018-08-09
Q4 2017 -$45.2M Dec 31, 2017 10-K 2019-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.